Philips develops ultrasound-activated microbubbles for localized delivery of cancer drugs

(PhysOrg.com) -- Philips is developing an ultrasound-based drug delivery technology that is designed to increase the effectiveness and reduce the side effects of chemotherapy treatment for certain types of cancer.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news142011994.html">Philips develops ultrasound-activated microbubbles for localized delivery of cancer drugs</a></p> <p>(PhysOrg.com) -- Philips is developing an ultrasound-based drug delivery technology that is designed to increase the effectiveness and reduce the side effects of chemotherapy treatment for certain types of cancer.</p>